⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
XOM
JPM
AMD
PYPL
MRNA
MSTR
SNOW
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
INTC
SPCX
Form 8-K
sec.gov
MRNA
Moderna to Present at Upcoming Conferences in September 2026
accessnewswire.com
MRNA
Europe Hyperscale Data Center Market Outlook & Forecast 2026-2031 | AI and Cloud Adoption Accelerate Europe's Data Center Expansion
globenewswire.com
ORCL
GOOGL
AMZN
AAPL
MSFT
DELL
HPE
NVDA
CSCO
ETN
SWKS
ADI
QCOM
AVGO
INTC
AMD
MU
AMAT
KLAC
LRCX
VRTX
GILD
BMY
PFE
MRNA
REGN
BIIB
ABBV
AMGN
ISRG
MDT
SYK
EW
GOOG
GOOGN
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
accessnewswire.com
MRNA
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
accessnewswire.com
MRNA
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
accessnewswire.com
MRNA
Global CD70-Targeting Therapies Market Report 2026 - Highlights Clinical Innovation, Pipeline Trends and Commercial Opportunities
globenewswire.com
ALLO
CRSP
JNJ
PFE
ADCT
REGN
MRNA
BMY
GILD
AMGN
BIIB
AZN
NVS
LLY
ABBV
Global mRNA Cancer Vaccines Market Report 2026-2031: Assesses More Than 70 Vaccines Through Phase III
globenewswire.com
BNTX
MRNA
CVAC
TRNS
mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More
globenewswire.com
ARCT
BNTX
MRNA